Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS42000890EBVENSG00000148408.15protein_codingCACNA1BNoNo774Q00975
TVIS30013793HIVENSG00000148408.15protein_codingCACNA1BNoNo774Q00975
TVIS30084602HIVENSG00000148408.15protein_codingCACNA1BNoNo774Q00975
TVIS30077938HIVENSG00000148408.15protein_codingCACNA1BNoNo774Q00975
TVIS30082163HIVENSG00000148408.15protein_codingCACNA1BNoNo774Q00975
TVIS30072769HIVENSG00000148408.15protein_codingCACNA1BNoNo774Q00975
TVIS20002068HPVENSG00000148408.15protein_codingCACNA1BNoNo774Q00975
TVIS20006574HPVENSG00000148408.15protein_codingCACNA1BNoNo774Q00975
TVIS20010570HPVENSG00000148408.15protein_codingCACNA1BNoNo774Q00975
TVIS20006108HPVENSG00000148408.15protein_codingCACNA1BNoNo774Q00975
TCGA Plot Options
Drug Information
GeneCACNA1B
DrugBank IDDB00661
Drug NameVerapamil
Target IDBE0002226
UniProt IDQ00975
Regulation Typeinhibitor
PubMed IDs10385261
CitationsDobrev D, Milde AS, Andreas K, Ravens U: The effects of verapamil and diltiazem on N-, P- and Q-type calcium channels mediating dopamine release in rat striatum. Br J Pharmacol. 1999 May;127(2):576-82. doi: 10.1038/sj.bjp.0702574.
GroupsApproved
Direct ClassificationPhenylbutylamines
SMILESCOC1=C(OC)C=C(CCN(C)CCCC(C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1
PathwaysVerapamil Action Pathway
PharmGKBPA451868
ChEMBLCHEMBL6966